Related Experiment Video
Updated: Apr 16, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Echocardiographic changes in patients with stage 3-5 chronic kidney disease and left ventricular diastolic
Leszek Gromadziński1, Piotr Pruszczyk2
1Department of Internal Diseases, Gastroenterology and Hepatology, University Clinical Hospital in Olsztyn, Olsztyn, Poland ; Department of Internal Diseases, Gastroenterology, Cardiology and Infectiology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Insights
Reduced mitral annular plane systolic excursion (MAPSE) is an independent predictor of left ventricular (LV) diastolic dysfunction in chronic kidney disease (CKD) patients. This finding aids in diagnosing heart failure in CKD individuals.
Area of Science:
- Cardiology
- Nephrology
- Echocardiography
Background:
- Left ventricular (LV) diastolic dysfunction is a common complication in chronic kidney disease (CKD) patients, often leading to congestive heart failure.
- Early detection and management of LV diastolic dysfunction are crucial for improving outcomes in CKD patients.
Purpose of the Study:
- To evaluate echocardiographic parameters in CKD patients with and without LV diastolic dysfunction.
- To identify independent predictors of LV diastolic dysfunction in CKD.
Main Methods:
- Seventy ambulatory CKD patients (stages 3-5) and 26 controls underwent standard echocardiography and tissue Doppler imaging.
- Patients were categorized into diastolic dysfunction (DD) and without diastolic dysfunction (WDD) groups based on lateral mitral early diastolic velocity (EmLVlat).
Main Results:
- Patients in the DD group exhibited significantly lower mitral annular plane systolic excursion (MAPSE) and lateral mitral annular systolic velocity (SmLVlat) compared to the WDD group.
- MAPSE demonstrated high diagnostic accuracy (Area Under Curve = 0.801) for LV diastolic dysfunction, with a threshold of ≤13 mm showing 84.4% sensitivity and 75.8% specificity.
- Reduced MAPSE was identified as the sole independent predictor of LV diastolic dysfunction in CKD patients (OR = 0.39).
Conclusions:
- Reduced MAPSE is a significant independent predictive factor for LV diastolic dysfunction in CKD patients.
- SmLVlat was not found to be an independent predictor in this cohort.
- MAPSE serves as a valuable echocardiographic marker for assessing diastolic function in CKD.
Background:
Left ventricular (LV) diastolic dysfunction in chronic kidney disease (CKD) patients frequently leads to the development of congestive heart failure. We evaluated changes in echocardiographic parameters among CKD patients with LV diastolic dysfunction.
Methods:
We examined 70 ambulatory patients with CKD at stages 3-5 and 26 patients without CKD as a control group. Standard echocardiography and tissue Doppler imaging were performed on all patients. Patients with CKD were divided into two groups according to the results of lateral mitral early diastolic velocity (EmLVlat): a group with diastolic dysfunction (DD group; EmLVlat <8 cm/s) and a group without diastolic dysfunction (WDD group; EmLVlat ≥8 cm/s).
Results:
Compared to the patients in the WDD group, those in the DD group were characterized by lower values of mitral annular plane systolic excursion [MAPSE; 13 (11-17) vs. 14 (11-16) mm, p < 0.0001] and lateral mitral annular systolic velocity [SmLVlat; 7 (5-14) vs. 8 (5-13) cm/s, p = 0.006]. The area under the receiver operating characteristic (ROC) curve of the MAPSE level for the detection of LV diastolic dysfunction was 0.801 [95% CI 0.684-0.890, p < 0.0001], whereas a ROC-derived MAPSE value of ≤13 mm was characterized by a sensitivity of 84.4% and a specificity of 75.8% for diagnosing LV diastolic dysfunction. The only independent variable predicting LV diastolic dysfunction was MAPSE [OR = 0.39; 95% CI 0.21-0.74, p = 0.003].
Conclusion:
We showed that reduced MAPSE, but not SmLVlat, is an independent predictive factor for LV diastolic dysfunction in CKD patients.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Chronic Kidney Disease III: Interprofessional Care
Pathophysiology of Heart Failure

